Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)

By sjmartinez • September 27, 2024

Kim NH, Channick R, Delcroix M, Madani M, Pepke-Zaba J, Borissoff JI, Easton V, Gesang S, Richard D, Ghofrani HA. Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial). Eur Respir J. 2024 Sep 26:2400193. doi: 10.1183/13993003.00193-2024. Epub ahead of print. PMID: 39326918.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults

O'Dwyer K, Winestone LE, Cheung MC, Benitez L, Buldini B, Cole PD, Damlaj M, Dholaria B, Dias AL, Dils A, Fritsch M, Greer J, Hayes-Lattin[...]

Quality measures in the design, conduct, and reporting of endoscopic research

Elmunzer BJ, Madhoun M, Cote GA, Cummings LC, Shahidi N, Srivastava N, Essex EA, Scheiman JM, May FP, Yen T, Barkun A, Durkalski-Mauldin V, Dominitz[...]

Premature Ventricular Contractions Ablated via the Left Ventricular Annular Vein: Demonstration of 3 Possible Approaches

Kanzaki Y, Morishima I, Mori S, Shimojo K, Tanaka Y, Yamada T. Premature Ventricular Contractions Ablated via the Left Ventricular Annular Vein: Demonstration of 3[...]